Clicca qui per scaricare il programma dell’evento
THURSDAY 16 December 2021
PLENARY SESSIONS – SALONE DEI CONTINENTI
RIUNIONE DEI GRUPPI DI LAVORO DEI PROGETTI ARIA E GINA
08:30-10:30 Progetto ARIA (Rinite)
Chairmen Giovanni Passalacqua and Carlo Lombardi
11:00-13:30 Progetto GINA (Asma)
Chairmen Pierluigi Paggiaro and Sergio Bonini
PLENARY SESSIONS – SALONE DEI CONTINENTI
14:30-15:30 PRO/CON DEBATE: MAINTENANCE AND RELIEVER THERAPY (MART) versus SINGLE INHALER TRIPLE THERAPY (SITT) IN MODERATE TO SEVERE ASTHMA
Chairpersons Bianca Beghè, Marco Contoli and Adriano Vaghi
Helen K. Reddel
MART IN STEP 4-5 ASTHMA
Leonardo M. Fabbri
SITT IN STEP 4-5 ASTHMA
15:30-16:45 TYPE 2 HIGH/LOW INFLAMMATION IN ASTHMA AND COPD
Chairpersons Maria Gabriella Matera, Girolamo Pelaia
and Fabio Luigi Massimo Ricciardolo
Klaus F. Rabe
SEVERE ASTHMA VERSUS COPD: DIFFERENTIAL DIAGNOSIS
Guy Brusselle
MANAGEMENT OF TYPE 2 LOW ASTHMA
John Fahy
THE CYTOKINES OF ASTHMA AND COPD
17:15-18:30 LECTURES
Chairpersons Marina Saetta and Marco Confalonieri
John Fahy
PATHOPHYSIOLOGY OF MUCUS IN ASTHMA AND COPD
Jean Bousquet
MULTIMORBIDITY IN ALLERGIC DISEASES: FROM REAL WORLD DATA TO GENOMICS
Luigi Camporota
MANAGEMENT RESPIRATORY FAILURE CAUSED BY COVID-19
18:30-19:30 CHRONIC COUGH
Chairmen Federico Lavorini and Antonio Spanevello
Surinderpal S. Birring
CLINICAL APPROACH TO CHRONIC COUGH
Jaclyn A. Smith
PATHOGENESIS OF CHRONIC COUGH
FRIDAY 17 December 2021
PLENARY SESSIONS – SALONE DEI CONTINENTI
RIUNIONE DEI GRUPPI DI LAVORO DEI PROGETTI GOLD E MULTIMORBIDITA’
08:30-11:00 Progetto GOLD (BPCO) e MULTIMORBIDITÀ
Chairmen Enrico M. Clini, Lorenzo Corbetta, Dario Manfellotto and Alberto Papi
11:30-13:30 OPEN DISCUSSION ON PIPELINES OF EXPERIMENTAL TREATMENTS FOR ASTHMA, ALLERGY/RHINITIS, COPD, MULTIMORBIDITY: PANEL DISCUSSION OF RD DIRECTORS OF THE MAIN RESPIRATORY PHARMA INDUSTRIES
Conductors Leonardo M. Fabbri, Pierluigi Paggiaro, Alberto Papi and Giovanni Passalacqua
PLENARY SESSIONS – SALONE DEI CONTINENTI
14:30-16:00 EXACERBATIONS OF COPD
Chairmen Leonardo M. Fabbri, Paolo Palange and Roberto Rodriguez-Roisin
Bartolome Celli
NEED OF A NEW DEFINITION OF COPD EXACERBATIONS
Klaus F. Rabe
EXACERBATIONS OF RESPIRATORY SYMPTOMS IN MULTIMORBID PATIENTS
Wisia Wedzicha
RISKS ASSOCIATED WITH EXACERBATIONS OF COPD
Raffaele F. Antonelli Incalzi
MANAGEMENT OF EXACERBATIONS OF RESPIRATORY SYMPTOMS IN MULTIMORBID PATIENTS
16:00-17:00 EARLY COPD
Chairmen Mario Cazzola and Manuel G. Cosio
Alvar Agusti
EARLY- preCOPD versus MILD COPD
Erik Melén
EARLY EVENTS IN COPD
Marco Contoli
EARLY PHYSIOLOGICAL DIAGNOSIS OF RESPIRATORY EFFECTS OF SMOKING
Fernando D. Martinez
EARLY EVENTS RESPONSIBLE FOR THE DEVELOPMENT OF COPD IN ADULTHOOD
17:30-19:00 MULTIPLE THERAPIES IN CHRONIC DISEASES
Chairmen Alfredo Chetta and Nunzio Crimi
Raffaele F. Antonelli Incalzi
MULTIPLE THERAPIES IN THE ELDERLY FRAIL MULTIMORBID PATIENT
Alberto Papi
MULTIPLE THERAPIES IN SEVERE COPD
Pierluigi Paggiaro
MULTIPLE THERAPIES IN SEVERE ASTHMA